Results 111 to 120 of about 39,546 (195)

Clozapine Augmentation: Safety and Efficacy [PDF]

, 2000
Siow Ann Chong, Gary Remington
openalex   +1 more source

Clozapine-Related Speech Disturbance

, 1997
James L. Knoll
openalex   +2 more sources

Beyond Acute Overdoses: A Case of Chronic Clozapine Toxicity With Non-specific Presentation. [PDF]

Cureus
Dildar S, Javaid MA.
europepmc   +1 more source

Determinants of patient satisfaction in clozapine users: results from the Clozapine International Consortium (CLOZIN). [PDF]

Schizophrenia (Heidelb)
van der Horst MZ, de Boer N, CLOZIN collaborators, Okhuijsen-Pfeifer C, Luykx JJ.   +4 more
europepmc   +1 more source

Behavioral pharmacological studies of OPC-14597, a novel antipsychotic drug : Comparison with OPC-4392, clozapine and haloperidol.

, 1996
Tetsuro Kikuchi, Yasufumi Uwahodo, Katsura Tottori, Masami Nakai, Tsuyoshi Hirose, Yasuo Oshiro, Seiji Morita   +6 more
openalex   +1 more source

The mechanism of action of clozapine. [PDF]

J Psychopharmacol
Morrison PD, Jauhar S, Young AH.
europepmc   +1 more source

Evaluating Reduced Blood Monitoring Frequency and the Detection of Hematological Abnormalities in Clozapine-Treated Patients With Schizophrenia: A Chart Review Study From the COVID-19 Pandemic. [PDF]

Schizophr Bull
Thai H, Preobrazenski N, Hsieh T, Robertson C, Owoeye O.   +4 more
europepmc   +1 more source

Clozapine for mitochondrial psychosis

Molecular Genetics and Metabolism Reports, 2017
Sinda Zarrouk-Mahjoub, Josef Finsterer
openaire   +3 more sources

Possible Myocarditis with Clozapine [PDF]

, 2000
Peter Stewart, Elizabeth McCrudden, Josie Ezzy   +2 more
openalex   +1 more source

S49.04 Impact of neurotic symptoms on the response to 4 years treatment with clozapine in drug resistant psychotic patients [PDF]

, 2000
Giovanni Battista Cassano, Antonio Ciapparelli   +1 more
openalex   +1 more source